Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in decades. The drug, called Cobenfy and developed by US pharma giant Bristol ...
Schizophrenia affects how a person thinks, feels and behaves, and can cause paranoia, delusions, hallucinations, and changes in emotions, movements and behavior. Those symptoms can disrupt a patient's ...
Hosted on MSN
With a New Take on an Old Schizophrenia Drug, LB Pharma Prepares IPO to Fund Phase 3 Test
Many drugs are available for schizophrenia, but insufficient efficacy and intolerable side effects leave an unmet need that biotech companies are still trying to fill. LB Pharmaceuticals is not ...
For the first time in decades, the Food and Drug Administration has approved a new type of drug for schizophrenia. The twice-a-day pill to be marketed by Bristol Myers Squibb will be called Cobenfy, ...
On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel treatment for schizophrenia in decades. Reading time 3 minutes People living with ...
"Cobenfy serves as a reminder for what works, and why our market-oriented system is worth preserving," writes healthcare policy expert Sally C. Pipes. The drug's journey from the lab through ...
Karuna Therapeutics and Bristol Myers Squibb are winners of the 2025 Gizmodo Science Fair for their research and development of Cobenfy (xanomeline-trospium), the first truly novel medication for ...
Key Points Interested in Maplight Therapeutics, Inc.? Here are five stocks we like better. ML-007C-MA met the Phase II ...
The Food and Drug Administration (FDA) approved Bristol Myers Squibb’s schizophrenia drug Cobenfy Thursday — the first new approved drug for the disease in some 30 years. The drug, a combination of ...
People with schizophrenia will have a new treatment option for the first time in more than three decades, after the Food and Drug Administration Thursday approved a new kind of drug. Studies showed ...
A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Md. automation The U.S. Food and Drug Administration (FDA) on Thursday approved the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results